Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 31 of Acrivon Therapeutics, Inc.'s SEC filings and found 1 warrant series, 1 ATM program, 2 shelf registrations, 1 S-1 registration and 1 completed offering on file for ACRV. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Sep 20, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
MNOVMediciNova, Inc.
TELOTelomir Pharmaceuticals, Inc. Common Stock
CSBRChampions Oncology, Inc.
CINGCingulate Inc.
TENXTenax Therapeutics, Inc.
MAIAMAIA Biotechnology, Inc.
NMADNOMAD Power Solutions, Inc.
CRDFCardiff Oncology, Inc.
COYACoya Therapeutics, Inc.
OKYOOKYO Pharma Limited Ordinary Shares
CGTXCognition Therapeutics, Inc.
CLLSCellectis S.A. American Depositary Shares
CRBPCorbus Pharmaceuticals Holdings, Inc.
FBIOFortress Biotech, Inc.
RANIRani Therapeutics Holdings, Inc.